Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort
Background: Ceftobiprole is a fifth-generation cephalosporin that has been approved in Europe solely for the treatment of community-acquired and nosocomial pneumonia. The objective was to analyze the use of ceftobiprole medocaril (Cefto-M) in Spanish clinical practice in patients with infections in...
Main Authors: | Carmen Hidalgo-Tenorio, Inés Pitto-Robles, Daniel Arnés García, F. Javier Membrillo de Novales, Laura Morata, Raul Mendez, Olga Bravo de Pablo, Vicente Abril López de Medrano, Miguel Salavert Lleti, Pilar Vizcarra, Jaime Lora-Tamayo, Ana Arnáiz García, Leonor Moreno Núñez, Mar Masiá, Maria Pilar Ruiz Seco, Svetlana Sadyrbaeva-Dolgova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/7/1218 |
Similar Items
-
Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort
by: Daniel Arnés García, et al.
Published: (2023-12-01) -
Real-life experience with ceftobiprole in a tertiary-care hospital
by: Emanuele Durante-Mangoni, et al.
Published: (2020-09-01) -
Ceftobiprole for the treatment of infective endocarditis: A case series
by: Carlo Tascini, et al.
Published: (2020-03-01) -
Ceftobiprole Perspective: Current and Potential Future Indications
by: Tommaso Lupia, et al.
Published: (2021-02-01) -
Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories
by: Stephen Hawser, et al.
Published: (2022-06-01)